InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
81.93
(
-0.07%
)
Bitcoin
68,836.30
(
0.47%
)
Post# of 251942
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

vinmantoo

Send PM Follow Ignore
Followers 30
Posts 4098
Boards Moderated 0
Alias Born 07/25/2007

vinmantoo

Re: willyw post# 251662

Wednesday, 05/01/2024 2:55:30 PM

Wednesday, May 01, 2024 2:55:30 PM

Post# of 251942

4) Somewhat unrelated, if it were such that Enanta's patent was upheld in court might that also serve to encourage a potential phase 3 trial collaboration?



Keep in mind that ENTA is suing PFE because they claim that Paxlovid violated one of ENTA's patents. ENTA's anti-Covid drug EDP-235 is not part of this patent dispute but is a different compound.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up